Key Events This Week
8 June: Intraday high of Rs.779.90 with a 7.44% surge
9 June: Mojo Score upgraded to Sell from Strong Sell
10 June: Price correction with a 2.00% decline
12 June: Week closes at Rs.769.00, up 1.75% for the week

Astec Lifesciences Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges
2026-06-09 08:21:53Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 8 June 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental weaknesses, prompting a reassessment of its risk and return profile by analysts at MarketsMOJO.
Read full news article
Astec Lifesciences Ltd Surges 7.44% to Day's High of Rs 779.9 — Outperforms Sector by 4.17 Percentage Points
2026-06-08 10:31:21The Sensex declined by 0.85% on 8 Jun 2026, while Astec Lifesciences Ltd surged 7.44%, outperforming its sector by 4.17 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.
Read full news article
Astec Lifesciences Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals
2026-06-03 08:02:47Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has exhibited a notable shift in price momentum, moving from a sideways trend to a mildly bullish stance. Despite a strong day change of 6.65%, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution. This article analyses the recent technical developments, price action, and relative performance against the broader market to provide investors with a comprehensive view.
Read full news article
Astec Lifesciences Ltd Surges 8.17% to Day's High of Rs 794.9 — Outperforms Sector by 7.42 Percentage Points
2026-06-02 11:02:41While the Sensex slipped 0.27% on 2 Jun 2026, Astec Lifesciences Ltd surged 8.17%, touching an intraday high of Rs 794.9. This 7.42-percentage-point outperformance over its Pesticides & Agrochemicals sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Astec Lifesciences Downgraded to Strong Sell Amid Technical and Fundamental Concerns
2026-06-02 08:25:29Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 June 2026. This shift reflects a complex interplay of deteriorating technical indicators, weak long-term financial trends, challenging valuation metrics, and subdued quality scores, signalling heightened risk for investors despite some recent operational improvements.
Read full news article
Astec Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-06-02 08:04:53Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock’s price action and technical indicators reveal a nuanced picture that investors should carefully analyse.
Read full news article
Astec Lifesciences Ltd is Rated Sell
2026-05-31 10:10:31Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Astec Lifesciences Ltd Surges 11.39% to Day's High of Rs 839.9 — Outperforms Sector by 10.96 Percentage Points
2026-05-29 11:17:09The Sensex edged up a modest 0.11% on 29 May 2026, while Astec Lifesciences Ltd surged 11.39%, marking a standout session in the Pesticides & Agrochemicals sector with an outperformance of nearly 11 percentage points. This sharp intraday gain rewrites the short-term narrative for the stock, raising the question of whether this is a breakout or a recovery rally within a broader trend.
Read full news article





